The Pseudoxanthoma Elasticum Treatment Market was valued at USD 0.25 billion in 2024 and is projected to reach USD 0.50 billion by 2034, registering a CAGR of 7.5%. This growth trajectory is underpinned by several factors, including the rising prevalence of pseudoxanthoma elasticum (PXE), increased awareness and diagnosis of the condition, and advancements in treatment options. The market is...